Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |